Last reviewed · How we verify
Glycemic Rescue 1 — Competitive Intelligence Brief
phase 3
Diabetes
Small molecule
Live · refreshed every 30 min
Target snapshot
Glycemic Rescue 1 (Glycemic Rescue 1) — Merck Sharp & Dohme LLC. Glycemic Rescue 1 is designed to rapidly restore blood glucose control in acute hyperglycemic states.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Glycemic Rescue 1 TARGET | Glycemic Rescue 1 | Merck Sharp & Dohme LLC | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Glycemic Rescue 1 CI watch — RSS
- Glycemic Rescue 1 CI watch — Atom
- Glycemic Rescue 1 CI watch — JSON
- Glycemic Rescue 1 alone — RSS
Cite this brief
Drug Landscape (2026). Glycemic Rescue 1 — Competitive Intelligence Brief. https://druglandscape.com/ci/glycemic-rescue-1. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab